Circana’s Diversity Advantage Program Welcomes a New
Initiative provides insights literacy to enable ongoing growth opportunities for women- and minority-owned businesses
Globe Newswire14-03-2023, 20:07
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T 31-05-2025, 08:00